63 related articles for article (PubMed ID: 25575524)
1. Effects of RING-SH2Grb², a chimeric protein containing the E3 ligase domain of Cbl, on the EGFR pathway.
Lee WH; Wang PY; Lin YH; Chou HY; Lee YH; Lee CK; Pai LM
Chin J Physiol; 2014 Dec; 57(6):350-7. PubMed ID: 25575524
[TBL] [Abstract][Full Text] [Related]
2. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.
Huang F; Sorkin A
Mol Biol Cell; 2005 Mar; 16(3):1268-81. PubMed ID: 15635092
[TBL] [Abstract][Full Text] [Related]
3. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
[TBL] [Abstract][Full Text] [Related]
4. c-CBL regulates melanoma proliferation, migration, invasion and the FAK-SRC-GRB2 nexus.
Nihal M; Wood GS
Oncotarget; 2016 Aug; 7(33):53869-53880. PubMed ID: 27472394
[TBL] [Abstract][Full Text] [Related]
5. The signal transduction through Grb2/Ash in hematopoietic cells.
Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma.
Hong SY; Kao YR; Lee TC; Wu CW
Cancer Res; 2018 Sep; 78(17):4984-4996. PubMed ID: 29945960
[TBL] [Abstract][Full Text] [Related]
7. Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis.
Sévère N; Dieudonné FX; Marty C; Modrowski D; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
J Bone Miner Res; 2012 Oct; 27(10):2108-17. PubMed ID: 22623369
[TBL] [Abstract][Full Text] [Related]
8. Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
Li X; Shen L; Zhang J; Su J; Shen L; Liu X; Han H; Han W; Yao L
Cancer Res; 2007 Sep; 67(18):8716-24. PubMed ID: 17875712
[TBL] [Abstract][Full Text] [Related]
9. Fusion protein based on Grb2-SH2 domain for cancer therapy.
Saito Y; Furukawa T; Arano Y; Fujibayashi Y; Saga T
Biochem Biophys Res Commun; 2010 Aug; 399(2):262-7. PubMed ID: 20655296
[TBL] [Abstract][Full Text] [Related]
10. Weak binding to E3 ubiquitin ligase c-Cbl increases EGFRvA protein stability.
Song F; Zhou M; Wang B; Shi B; Jiang H; Zhang J; Li Z
FEBS Lett; 2016 May; 590(9):1345-53. PubMed ID: 27059931
[TBL] [Abstract][Full Text] [Related]
11. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
[TBL] [Abstract][Full Text] [Related]
12. δ-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer.
Shrestha N; Shrestha H; Ryu T; Kim H; Simkhada S; Cho YC; Park SY; Cho S; Lee KY; Lee JH; Kim K
Mol Cells; 2018 Apr; 41(4):320-330. PubMed ID: 29629558
[TBL] [Abstract][Full Text] [Related]
13. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
[TBL] [Abstract][Full Text] [Related]
14. A mutant EGF-receptor defective in ubiquitylation and endocytosis unveils a role for Grb2 in negative signaling.
Waterman H; Katz M; Rubin C; Shtiegman K; Lavi S; Elson A; Jovin T; Yarden Y
EMBO J; 2002 Feb; 21(3):303-13. PubMed ID: 11823423
[TBL] [Abstract][Full Text] [Related]
15. Cbl-family ubiquitin ligases and their recruitment of CIN85 are largely dispensable for epidermal growth factor receptor endocytosis.
Ahmad G; Mohapatra BC; Schulte NA; Nadeau SA; Luan H; Zutshi N; Tom E; Ortega-Cava C; Tu C; Sanada M; Ogawa S; Toews ML; Band V; Band H
Int J Biochem Cell Biol; 2014 Dec; 57():123-34. PubMed ID: 25449262
[TBL] [Abstract][Full Text] [Related]
16. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.
Smit L; van der Horst G; Borst J
Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377
[TBL] [Abstract][Full Text] [Related]
17. Cbl escapes Cdc42-mediated inhibition by downregulation of the adaptor molecule betaPix.
Schmidt MHH; Husnjak K; Szymkiewicz I; Haglund K; Dikic I
Oncogene; 2006 May; 25(21):3071-8. PubMed ID: 16407834
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
20. The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility.
Kiuchi T; Ortiz-Zapater E; Monypenny J; Matthews DR; Nguyen LK; Barbeau J; Coban O; Lawler K; Burford B; Rolfe DJ; de Rinaldis E; Dafou D; Simpson MA; Woodman N; Pinder S; Gillett CE; Devauges V; Poland SP; Fruhwirth G; Marra P; Boersma YL; Plückthun A; Gullick WJ; Yarden Y; Santis G; Winn M; Kholodenko BN; Martin-Fernandez ML; Parker P; Tutt A; Ameer-Beg SM; Ng T
Sci Signal; 2014 Aug; 7(339):ra78. PubMed ID: 25140053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
